Abstract
The number of anterior cruciate ligament injuries in female athletes exceeds that in male athletes at similar competitive levels. This difference has been attributed by some authors to hormone-mediated alteration in knee laxity in women. Sheep anterior cruciate and medial collateral ligament strength and stiffness are not altered by administration for 6 months of estrogen or a selective estrogen receptor agonist (raloxifene). Controlled laboratory study. Thirty-eight mature ewes were divided into five groups: sham operation (N = 6), ovariectomy (N = 9), ovariectomy and estradiol implant (N = 7), low-dose raloxifene (N = 9), and high-dose raloxifene (N = 7). After 6 months, the animals were sacrificed and ligaments were tested along with those from five rams' knees. No differences were found between treatment groups for maximum force, stiffness, energy to failure, or failure site. The ultimate stress of the rams' anterior cruciate ligaments was significantly higher than that of the ewes. Estrogen and estrogen receptor agonists at physiologic levels do not lead to decreased knee ligament strength. The female hormonal milieu may not be responsible for the increased incidence of anterior cruciate ligament injury in female athletes compared with their male counterparts.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
